| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.94B | 8.74B | 9.15B | 10.88B | 12.46B | 8.66B |
| Gross Profit | 4.21B | 2.50B | 4.98B | 5.90B | 6.88B | 4.22B |
| EBITDA | 2.73B | 3.35B | 4.05B | 4.69B | 4.98B | 2.77B |
| Net Income | 771.00M | 1.24B | 1.13B | 2.08B | 3.64B | 1.42B |
Balance Sheet | ||||||
| Total Assets | 22.29B | 20.39B | 19.25B | 19.99B | 15.06B | 14.05B |
| Cash, Cash Equivalents and Short-Term Investments | 26.00M | 280.00M | 42.00M | 3.00M | 5.00M | 195.00M |
| Total Debt | 7.70B | 7.53B | 6.29B | 6.68B | 4.49B | 5.78B |
| Total Liabilities | 10.74B | 9.20B | 8.92B | 9.62B | 7.37B | 8.98B |
| Stockholders Equity | 11.56B | 11.20B | 10.33B | 10.37B | 7.69B | 5.07B |
Cash Flow | ||||||
| Free Cash Flow | 3.82B | 1.50B | 1.42B | 1.42B | 2.04B | 1.61B |
| Operating Cash Flow | 3.81B | 3.65B | 3.72B | 4.17B | 3.87B | 3.13B |
| Investing Cash Flow | -3.71B | -2.88B | -2.46B | -5.52B | -1.79B | -525.00M |
| Financing Cash Flow | -71.42M | -762.00M | -1.23B | 1.36B | -2.27B | -2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $9.24B | 10.26 | 20.93% | 1.00% | 23.03% | 239.04% | |
72 Outperform | $10.88B | 11.50 | 12.71% | ― | 24.26% | 323.40% | |
71 Outperform | $12.94B | 8.44 | 25.11% | 3.80% | -17.38% | 54.99% | |
69 Neutral | $16.18B | 24.16 | 6.32% | 4.27% | -1.12% | -48.40% | |
68 Neutral | $15.64B | 19.41 | 7.11% | 3.16% | -0.59% | 32.83% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
61 Neutral | $6.52B | 13.75 | 8.74% | 3.14% | -2.91% | -47.92% |